| 词条 | Wockhardt |
| 释义 |
|name = Wockhardt Ltd. |type = Public company (NSE: WOCKPHARMA) |logo = Wockhardt Logo.png |foundation = 1960s |founder = Habil Khorakiwala |location = Mumbai, India |area_served = Worldwide |key_people = Habil Khorakiwala (Chairman) Murtaza Khorakiwala (managing director) [1] (Executive Director) |industry = Pharmaceuticals Health care |products = Formulations Biopharmaceuticals Nutrition products Vaccines |revenue = {{profit}} {{INRConvert|46.14|b}}[2] |operating_income = |net_income = |assets = |equity =$1.4 billion |num_employees = 7,900 (2013) |homepage = www.wockhardt.com }}Wockhardt Ltd. is a Global pharmaceutical and biotechnology company headquartered in Mumbai, India. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. It is a global company with more than half of its revenue coming from Europe.[3][4] In 2011–2012 its UK and USA sales alone were {{USD}}475 million.[5] It has market presence in emerging markets such as Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait.[6] The Company has a market capitalisation of over {{INRConvert|211|b}}[7] and an annual turnover of {{INRConvert|36|b}}.{{citation needed|date=March 2013}} It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs).[8] The company employs over 8,600 people globally.[9] Wockhardt Hospitals is a subsidiary of the Wockhardt Group.[10] HistoryWockhardt was founded by Dr. Habil Khorakiwala in the 1960s.[11] His father Fakhruddin T. Khorakiwala had acquired Worli Chemical Works[12] in 1959. This was incorporated as Wockhardt Pvt. Ltd., in 1973.[3] Wockhardt Ltd. was incorporated on July 8.1999.[13] Wockhardt is often confused as a multinational because of its German-sounding name.[14] Wockhardt is the first company outside the US and Europe to manufacture recombinant human insulin.[15] Acquisitions and subsidiariesWockhardt's acquisitions include Wallis Laboratory, UK (1998), Merind, India (1998), CP Pharmaceuticals, UK (2003), Espharma GmbH, Germany (2004), Dumex India (2006), Pinewood Laboratory, Ireland (2006), Morton Grove, US (2007),[16] and Negma, France (2007).[3] Wockhardt's debt following the acquisitions was close to Rs 38 billion, and Habil Khorakiwala quit as managing director.[17] The board of directors, on 31 March 2009 approved the appointments of Habil Khorakiwala's sons Murtaza Khorakiwala and Hozaifa Khorakiwala as managing director and Executive Director respectively As of April 28, 2017, the consensus forecast amongst 2 polled investment analysts covering Wockhardt Limited advises that the company will underperform the market. This has been the consensus forecast since the sentiment of investment analysts deteriorated on November 17, 2016. The previous consensus forecast advised investors to hold their position in Wockhardt Limited.[18] Wockhardt HospitalsWockhardt Hospitals[19]{{Better source|reason=per WP:CIRCULAR|date=February 2018}} are one of the tertiary care, super speciality healthcare networks in India offering healthcare services. Wockhardt hospitals, originally called First hospitals and Heart Institute, were one of the early movers among corporate health-care chains in India. The company was established in 1989 and it started its first operations with a medical center in Kolkata, 1989 and a heart hospital in Bangalore two years later. Today, the company has its presence across India with 9 multi-speciality hospital networks. This group of 9 hospitals caters to the need of the community in its chosen field of super specialty like Cardiology, Orthopedics, Neurology, Gastroenterology, Urology, Aesthetics and Minimal Access Surgery. Wockhardt Hospitals was incorporated on 28 August 1991 under the Companies Act, 1956 as a public limited company. In October 2000, the name was changed to Wockhardt Hospitals Limited. Corporate Social ResponsibilityWockhardt Foundation is a national, not-for-profit organization engaged in social service and human welfare activities. Its 18 programmes have made a perceptible change in its areas of operation to the lives of the underprivileged.[20] Wockhardt Foundation, in collaboration with various partners including Wockhardt Hospitals implements a host of social initiatives based on principles of optimising resources, minimising costs and maximising delivery of effective long-term solutions and services. Wockhardt Foundation’s social initiatives include mobile medical services, toy libraries, sanitation, e-learning, skill learning, etc. The CSR activities impact nearly 3 million lives every year.[20] References1. ^Huzaifa Khorakiwala 2. ^{{cite web|url=http://www.wockhardt.com/who-we-are/fact-sheet.aspx|title=Wockhardt:Fact Sheet |publisher=Wockhardt |accessdate=16 July 2010}} 3. ^1 2 {{cite journal|author=Sanju Verma, Amit Shah|year=2007|title=Wockhardt : "Wock"ing the talk...|periodical=HDFC securities|series=India Research|url=http://birlaa.com/wp-filez/Wockhardt%20Company%20Report.pdf}} 4. ^{{cite web|url=http://www.business-standard.com/article/companies/wockhardt-set-to-join-billion-dollar-club-113031900413_1.html |title=Wockhardt set to join billion-dollar club |publisher=Business Standard |date= 20 March 2013 |accessdate=20 March 2013}} 5. ^{{cite web|url=http://www.wockhardt.com/who-we-are/fact-sheet.aspx |title=Who we are | Fact Sheet |publisher=Wockhardt |accessdate=20 March 2013}} 6. ^{{cite web|url=http://www.wockhardt.com/who-we-are/overview.aspx |title=Who we are | Overview |publisher=Wockhardt |accessdate=20 March 2013}} 7. ^{{cite web|url=http://www.business-standard.com/stocks/company-overview/8021-wockhardt |title=Wockhardt Ltd – Price, Fundamentals, Charts, Financials |publisher=Business Standard |accessdate=20 March 2013}} 8. ^{{cite web|url=http://www.wockhardt.com/about_us.html|title=ABOUT US – Who We Are}} 9. ^{{cite web|title=Wockhardt Overview|url=http://www.wockhardt.com/who-we-are/overview.aspx|website=Wockhardt|accessdate=13 February 2017}} 10. ^{{cite web|url=http://www.wockhardt.com/web_sites.html|title=OUR OTHER WEBSITES}} 11. ^{{cite web|title=Wockhardt Chairman's Profile|url=http://www.wockhardt.com/who-we-are/chairmans-profile.aspx|website=www.wockhardt.com|accessdate=13 February 2017}} 12. ^{{cite news|url=http://economictimes.indiatimes.com/Corporate_Dossier/Marginal_business_logic/articleshow/2905713.cms|title=Marginal business logic|author=Priyanka Sangani|work=The Economic Times|date=28 March 2008}} 13. ^{{cite web|url=http://www.pharmabiz.com/redfr.asp?fn=/comprof/wockhardt.asp |archive-url=https://archive.is/20071020220413/http://www.pharmabiz.com/redfr.asp?fn=/comprof/wockhardt.asp |dead-url=yes |archive-date=20 October 2007 |title=Wockhardt Limited |accessdate=9 May 2009 }} 14. ^{{cite web|url=http://timesofindia.indiatimes.com/articleshow/msid-2712332,prtpage-1.cms|author=T. Surendar, Charles Assisi|date=18 January 2008|title='We need a Nano for medicines too'|work=The Times of India}} 15. ^{{cite web|url=http://www.wockhardt.co.uk/aboutus/wockhardtinternational.asp|title=Introducing Wockhardt|accessdate=9 May 2009}} 16. ^[https://www.reuters.com/article/idUSBOM9529820071024 Wockhardt buys US Morton Grove for $38 mln] 17. ^{{cite web|url=http://www.business-standard.com/india/news/newsmaker-habil-f-khorakiwala/353842/|title=Newsmaker: Habil F Khorakiwala, Scientist in a hurry|author=Shobhana Subramanian|date=3 April 2009|publisher=Business Standard}} 18. ^{{cite web|url=http://www.dancewithshadows.com/pillscribe/murtaza-khorakiwala-is-new-md-of-wockhardt-hozaifa-new-executive-director/|title=Murtaza Khorakiwala is new MD of Wockhardt, Huzaifa new Executive Director|date=2 April 2009|publisher=DWS Pill Scribe}} 19. ^Wockhardt Hospitals 20. ^1 http://wockhardtfoundation.org/aboutus.aspx External links
3 : Pharmaceutical companies of India|Companies based in Mumbai|Pharmaceutical companies established in 1960 |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。